Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology

Glioblastoma (GBM) is a malignant brain tumor exhibiting rapid and infiltrative growth, with less than 10% of patients surviving over 5 years, despite aggressive and multimodal treatments. The poor prognosis and the lack of effective pharmacological treatments are imputable to a remarkable histologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Tonon, Caterina, Lodi, Raffaele, Agati, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775324/
https://www.ncbi.nlm.nih.gov/pubmed/36551961
http://dx.doi.org/10.3390/biomedicines10123205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775324/
https://www.ncbi.nlm.nih.gov/pubmed/36551961
http://dx.doi.org/10.3390/biomedicines10123205

Ejemplares similares